SANA reports 1 year survival of transplanted insulin producing islets without immunosuppression

[https://www.tradingview.com/news/urn:summary\_document\_transcript:quartr.com:2599568:0-sana-gene-edited-cell-therapy-for-type-1-diabetes-shows-durable-immune-evasion-phase-i-trials-planned/](https://www.tradingview.com/news/urn:summary_document_transcript:quartr.com:2599568:0-sana-gene-edited-cell-therapy-for-type-1-diabetes-shows-durable-immune-evasion-phase-i-trials-planned/)